bet tar ghk cu Ionic-liquid-based delivery carrier enhances GHK-Cu transdermal GHK-Cu - Pure Health Peptides
Description
Regulatory Status in Canada BPC-157 is not approved by Health Canada as a therapeutic product
Read our GHK-Cu vs BPC-157 comparison
Clin Ther 33: 358-371
Blood levels and urinary excretion of vitamin B12 in man after a single parenteral dose of aqueous hydroxocobalamin, aqueous cyanocobalamin and cyanocobalamin zinc-tannate complex
GHK-Cu has pro-angiogenic properties (it promotes blood vessel formation)
Methods Ethics declarations All the animal experiments were performed following the Guide for Care and Use of Laboratory Animals, approved by the Animal Experimentation Ethics Committee of China Pharmaceutical University (2022-10-017)
